Significance of neuropathy symptom and disability scores in the diagnosis of neuropathy in diabetic patients

Neurology Psychiatry and Brain Research

Volumn 14, Issue 2, 2007, Pages 45-50

  Senol, Mehmet Guney ^a   Saracoglu, Mehmet ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Diabetic neuropathy; Modified Rankin disability scale; Nerve conduction; Neuropathy impairment score; Neuropathy symptom score; Sympathetic skin response

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANAMNESIS; ARTICLE; BIOCHEMISTRY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIAGNOSTIC VALUE; DISEASE DURATION; ELECTRODIAGNOSIS; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOSPITAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NEUROPATHY IMPAIRMENT SCORE; NEUROPATHY SYMPTOM SCORE; NEUROPHYSIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANKIN SCALE; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL; WORLD HEALTH ORGANIZATION;

EID: 37349038193     PISSN: 09419500     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJM (1998) Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 21: 1071-1075
2. American Diabetes Association, American Academy of Neurology (1988) Report and recommendations of the San Antonio Conference on Diabetic Neuropathy (Consensus Statement). Diabetes Care; 11:592-597.
3. American Diabetes Association. Standards of medical care in diabetes (2005) (Position Statement) [published correction appears in Diabetes Care.] 28 (SuppI1):4-36.
4. Apfel SC, Asbury AK, Bril V, et al (2001) for the Ad Hoc Panel on Endpoints for Diabetic Neuropathy Trials. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.J Neurol Sci. 189:3-5.
5. Boulton AJ, Knight G, DruryJ, WardJD (1985) The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care. 8:125-128.
6. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM (2004) Diabetic somatic neuropathies. Diabetes Care. 27:1458-1486.
7. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D (2005) American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. Apr;28(4):956-62.
8. Coppini DV, Bowtell PA, Weng C, Young PJ, Sönksen PH (2000) Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model. J Clin Epidemiol 53: 519-523.
9. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA et al (1980) Human diabetic endoneurial sorbitol,fructose and myo-inositol related to sural nerve morphometry. Ann Neurol 6: 590-596.
10. Dyck PJ, Kratz KM, Karnes JL, et al (1993) The prevalence bystaged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology Apr; 43(4):817-24.
11. Dyck PJ, Karnes JL, Daube J, O'Brien P, Service JF (1985) Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 108: 861-880
12. Dyck PJ (1988) Detection, characterization and staging ofpolyneuropathy: assessed in diabetics. Muscle Nerve 11: 21-32.
13. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ, O'Brien PC et al (1991) The Rochester diabetic neuropathy study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology; 41: 799-807.
14. Feki I, Lefaucheur J.P (2001) Correlation Between Nerve Conduction Studies and Clinical Scores in Diabetic Neuropathy. Muscle and Nerve, 24:555-558.
15. Forsblom CM, Sane T, Groop PH, Totterman KJ, Kallio M, Saloranta C et al (1998) Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 4:1253-1262.
16. Galer BS, Gianas A, Jensen MP (2000) Painful diabetic neuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47: 123-128.
17. Hang CY, Chia SE, Fang SK (1998) Neuropathy in non-insulindependent diabetes mellitus. The significance of symptoms. ScandJ Prim Health Care. 16:233-237.
18. Harris M, Eastman R, Cowie C (1993) Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care. 16:1446-1452.
19. ISJ Merkies, G Lauria (2004) Workshop report 131st ENMC International workshop: Selection of Outcome Measures for Peripheral Neuropathy Clinical Trials, 10-12 December, Naarden, The Netherlands Neuromuscular Disorders Feb16 (2):149-56.
20. Katz JS, Wolfe GI, Bryan WW, et al (1997) Electrophysiologic findings in multifocal motor neuropathy. Neurology 48:700-7.
21. Marchettini P, Teloni L, Formaglio F, Lacerenza M (2004) Pain in diabetic neuropathy case study: Whole patient management. EurJ Neurol. 11 (Suppl1): 12-21.
22. Maser RE, Steenkiste AR, Dorman JS, et al (1989) Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes. 38:1456-1461.
23. Meijer JWG, van Sonderen E, Blaauwwiekel EE, Smit AJ, Groothoff JW, Eisma WH, Links TP (2000) Diabetic Neuropathy Examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care 23:750-753.
24. Meijer JWG, Smit AJ, van Sonderen E, Groothoff JW, Eisma WH, Links TP (2002) Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med; 19:962-965.
25. Meijer JWG, Bosma E, Efrandt JD, Links TP, Smit AJ, Stewart RE, Van Der Hoeven JH, Hoogenberg K (2003) Clinical Diagnosis of Diabetic Polyneuropathy With the Diabetic Neuropathy Symptom and Diabetic Neuropathy Examination Scores: Diabetes Care;26:697-701.
26. Moghtaderi A , Bakhshipour A, Rashidi H (2006) Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy: Clinical Neurology and Neurosurgery Jul;108(5):477-81.
27. O'Hare JA, Abuaisha F, Geoghegan M (1994) Prevalence and forms of neuropathic morbidity in 800 diabetics. IrJ Med Sci.163:132-135.
28. Resnick HE, Vinik AI, Schwartz AV, Leveille SG, Brancati FL, Balfour J et al (2000) Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age. The Women's Health and Aging Study. Diabetes Care 23: 1642-1647.
29. Shaw JE, Zimmet PZ (1999) The epidemiology of diabetic neuropathy. Diabetes Rev 7: 245-252.
30. Trajoborg W (1996) The Electrophysiologic Profile of Diabetic Neuropathy. Seminary in Neurology, 16(2),:123-127.
31. Valk GD, Grootenhuis PA, Bouter LM, Bertelsmann FW (1994) Complaints of neuropathy related to the clinical and neurophysiological assessment of nerve function in patients with diabetes mellitus. Diabetes Res Clin Pratt.;26:29-34.